# BridgeBio Pharma, Inc.: Form SC 13D, filed Aug 1, 2018

- Company: [BridgeBio Pharma, Inc.](/companies/bbio.md) (CIK 1743881)
- Form: SC 13D
- Filed: 2018-08-01
- Accepted by EDGAR: Aug 1, 2018, 08:02 ET
- Period: not reported
- Accession: 0001193125-18-233959
- Inline XBRL: no
- Main document: https://www.sec.gov/Archives/edgar/data/1743881/000119312518233959/d590999dsc13d.htm
- All documents and exhibits: https://www.sec.gov/Archives/edgar/data/1743881/000119312518233959/

## Sections

Sections are extracted only from 10-K and 10-Q reports. Read this filing’s documents on sec.gov. https://www.sec.gov/Archives/edgar/data/1743881/000119312518233959/d590999dsc13d.htm

Filed Aug 1, 2018.
Source: SEC EDGAR, the filing index for accession 0001193125-18-233959. Last ingested by Listed: Nov 12, 2026, 17:56 ET. No prices; not investment advice.
